APA (7th ed.) Citation

Lütjohann, D., Stellaard, F., & Björkhem, I. (2020). Levels of 7alpha-hydroxycholesterol and/or 7alpha-hydroxy-4-cholest-3-one are the optimal biochemical markers for the evaluation of treatment of cerebrotendinous xanthomatosis. Journal of neurology, 267(2), 572-573. https://doi.org/10.1007/s00415-019-09650-0

Chicago Style (17th ed.) Citation

Lütjohann, Dieter, Frans Stellaard, and Ingemar Björkhem. "Levels of 7alpha-hydroxycholesterol And/or 7alpha-hydroxy-4-cholest-3-one Are the Optimal Biochemical Markers for the Evaluation of Treatment of Cerebrotendinous Xanthomatosis." Journal of Neurology 267, no. 2 (2020): 572-573. https://doi.org/10.1007/s00415-019-09650-0.

MLA (9th ed.) Citation

Lütjohann, Dieter, et al. "Levels of 7alpha-hydroxycholesterol And/or 7alpha-hydroxy-4-cholest-3-one Are the Optimal Biochemical Markers for the Evaluation of Treatment of Cerebrotendinous Xanthomatosis." Journal of Neurology, vol. 267, no. 2, 2020, pp. 572-573, https://doi.org/10.1007/s00415-019-09650-0.